The U.S. Drug Enforcement Administration (DEA) is poised to reclassify marijuana as a less hazardous substance, signaling a profound shift in the nation’s drug policy that has stood for generations. This historic move could send waves across the country, impacting everything from medical research to law enforcement.
The landmark proposed reclassification, which is currently under review by the White House Office of Management and Budget (OMB), would shift marijuana from a Schedule I to a Schedule III drug. This change would place cannabis alongside substances like ketamine and certain anabolic steroids, rather than its current classification with heroin and LSD.
Tags: Legislation Marijuana Policy New Drug Trend
